Literature DB >> 3110970

Diabetic ketoacidosis: effective low-cost treatment in a community hospital.

J M Moss.   

Abstract

Diabetic ketoacidosis can be effectively and economically treated by using low-dose intravenous insulin and 2 to 3 liters of isotonic saline at 500 ml/hr to replace extracellular fluids, followed by 2 to 4 L of 5% glucose in 0.45% saline with potassium chloride and/or potassium phosphate to replace intracellular fluids at 250 ml/hr. During the first six to nine hours serum glucose and potassium are measured every two to three hours, and bicarbonate, sodium, and chloride every four to six hours. Determination of arterial blood gas and serum ketone levels, electrocardiograms, and chest x-ray films are done only when indicated, and not routinely. Few patients need to be treated in an intensive care unit, and most can be discharged in three days. This protocol has been safe and effective without mortality in 250 consecutive patients. By eliminating unnecessary laboratory tests, costs have been greatly reduced without deterioration in results.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110970     DOI: 10.1097/00007611-198707000-00017

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

Review 1.  Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.

Authors:  Maya Fayfman; Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Med Clin North Am       Date:  2017-05       Impact factor: 5.456

Review 2.  Diabetic and endocrine emergencies.

Authors:  T Kearney; C Dang
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

Review 3.  Diagnosis and management of metabolic acidosis: guidelines from a French expert panel.

Authors:  Boris Jung; Mikaël Martinez; Yann-Erick Claessens; Michaël Darmon; Kada Klouche; Alexandre Lautrette; Jacques Levraut; Eric Maury; Mathieu Oberlin; Nicolas Terzi; Damien Viglino; Youri Yordanov; Pierre-Géraud Claret; Naïke Bigé
Journal:  Ann Intensive Care       Date:  2019-08-15       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.